BioSpace News Archive

The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), today announced NorthWest EHealth (NWEH) and Discover-NOW, the Health Data Research Hub for Real World Evidence, as its newest Network Collaborator partnership and first international addition to its Research Network.

Rahan Meristem, with the aid of our Colombian partner Mr. Luis Alberto Restrepo President of Banarica Colombia, developed Cavendish banana plants with apparent resistance to Panama disease TR4, reports the Scientific Director Dr. Eli Khayat.

Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that health insurance coverage of more than 50 million lives were added for the Sonata® treatment within the first 6 months of 2020.

Ag-West Bio Inc. welcomes four new members to its board of directors. Erin Armstrong (Barley Council of Canada), Drew Britz (Saskatoon Airport Authority (retired)), Shannon Hood-Niefer (Saskatchewan Food Industry Development Centre), and Chris Masich (McKercher LLP) were voted in at the June 2020 annual meeting of members.

Athersys, Inc. will release its second quarter 2020 financial results at approximately 4:00 PM Eastern Time on Monday, August 10, 2020, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.

Research Presentation Strategies (RPS), the leader in FDA advisory committee (AdComm) presentation support, announced the use of their technology platform for a successful virtual Cardio-Renal Drug Advisory Committee (CRDAC) meeting that took place on July 15, 2020.

Orthopaedic surgeons caution as parks, playing fields and courts slowly open to the public

Cigna and Memorial Hermann Health System have reached a multi-year agreement that ensures Cigna customers will have continued access to Memorial Hermann’s hospitals, facilities and providers for quality care at predictable, affordable rates.

Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the issuance of $13.8 million aggregate principal amount of 9.5% Series C Senior Convertible Notes due 2023 (the “New 2023 Notes”). After taking into account an original issue discount and other transaction fees (including fees payable to the purchasers in the form of additional New 2023 Notes), the Com

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced certain preliminary unaudited results for the second quarter 2020.